Prism Medico and Pharmacy Ltd

Prism Medico & Pharmacy Reports Zero Investor Complaints in Q3 2025 📊

- Zero investor complaints for the quarter ended December 31, 2025.

- No complaints pending at the start, received during, or resolved in the quarter.

- Scrip code: 512217 | ISIN: INE730E01016.

- Report submitted to BSE Limited and Metropolitan Stock Exchange of India Limited (MSE).

- Prepared by Purva Sharegistry (India) Pvt. Ltd. and signed by Director Bhavender Singh (DIN: 09447213).